Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota

Journal of Clinical Pharmacy and Therapeutics

Volumn 31, Issue 6, 2006, Pages 599-604

  Hill, L L ^a   Foote, J C ^a   Erickson, B D ^b   Cerniglia, C E ^b   Denny, G S ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Botanical supplement; Dietary supplement; Echinacea purpurea; Gastrointestinal microbiota; Herbal supplement; Human

Indexed keywords

ECHINACEA PURPUREA EXTRACT; ECHINAMIDE;

ADULT; AEROBIC BACTERIA; ANAEROBIC BACTERIUM; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTEROIDES; BACTEROIDES FRAGILIS; BIFIDOBACTERIACEAE; CANCER RISK; COLON CANCER; DIARRHEA; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; ECHINACEA PURPUREA; ENTERITIS; ENTEROBACTERIACEAE; ENTEROCOCCUS; FEMALE; FLATULENCE; GASTROINTESTINAL INFECTION; HUMAN; HUMAN EXPERIMENT; IN VITRO SELECTION; INTESTINE FLORA; LACTOBACILLUS; MALE; NAUSEA; NORMAL HUMAN;

ADULT; COLONY COUNT, MICROBIAL; DIETARY SUPPLEMENTS; ECHINACEA; FEMALE; GASTROINTESTINAL TRACT; HUMANS; MALE;

EID: 33751353422     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2006.00781.x     Document Type: Article

References (27)

1. Schaffer DM, Gordon NP, Jensen CD, Avins AL (2003) Nonvitamin, nonmineral supplement use over a 12-month period by adult members of a large health maintenance organization. Journal of the American Dietetic Association, 103, 1500-1505.
2. Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complementary and alternative medicine use among adults: United States, 2002. Advance data from vital health and statistics; no. 343. Hyattsville, MD, National Center for Health Statistics.
3. Xie L, Hettiarachchy NS, Jane ME, Johnson MG (2003) Antimicrobial activity of Ginkgo biloba leaf extract on Listeria monocytogenes. Journal of Food Science, 68, 268-270.
4. Ettayebi K, Yamani JE, Rossi-Hassani B (2000) Synergistic effects of nisin and thymol on antimicrobial activities in Listeria monocytogenes and Bacillus subtilis. FEMS Microbiology Letters, 183, 191-195.
5. Lee KL, Kim H, Moon KH, Shin KH (1998) Screening and isolation of antibiotic resistance inhibitors from herb-materials - resistance inhibition of volatile components of Korean aromatic herbs. Archives of Pharmacal Research, 21, 62-66.
6. Voravuthikunchai S, Lortheeranuwat A, Jeeju W, Sririrak T, Phongpaichit S, Supawita T (2004) Effective medicinal plants against enterohemorrhagic Escherichia coli O157:H7. Journal of Ethnopharmacology, 94, 49-54.
7. Draughon FA (2004) Use of botanicals as biopreservatives in foods. Food Technology, 58, 20-28.
8. Ward PML, Fasitsas S, Katz SE (2002) Inhibition, resistance development, and increased antibiotic and antimicrobial resistance caused by nutraceuticals. Journal of Food Protection, 65, 528-533.
9. Bae E, Han MJ, Kim E, Kim D (2004) Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of the transformants. Archives of Pharmacal Research, 27, 61-67.
10. Brigidi P, Swennen E, Vitali B, Rossi M, Matteuzzi D (2003) PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption. International Journal of Food Microbiology, 81, 203-209.
11. Ouwehand AC, Kurvinen T, Rissanen P (2004) Use of a probiotic Bifidobacterium in a dry food matrix, an in vivo study. International Journal of Food Microbiology, 95, 103-106.
12. Kruse HP, Kleessen B, Blaut M (1999) Effects of inulin of faecal Bifidobacteria in human subjects. British Journal of Nutrition, 82, 375-382.
13. Lee H (2005) Clinical effects of intake of Juice Valley and Gogu Valley toward fecal microbiota of healthy human volunteers. Food Science and Biotechnology, 14, 540-542.
14. Mai V, Katki HA, Harmsen H, Gallaher D, Schatzkin A, Baer DJ, Clevidence B (2004) Effects of a controlled diet and black tea drinking on the fecal microbiota composition and the fecal bile acid profile of human volunteers in a double-blinded randomized feeding study. Journal of Nutrition, 134, 473-478.
15. Malinen E, Rinttila T, Kajander K et al. (2005) Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. American Journal of Gastroenterology, 100, 373-382.
16. Zhao HY, Wang HJ, Lu Z, Xu SZ (2004) Intestinal microbiota in patients with liver cirrhosis. Chinese Journal of Digestive Diseases, 5, 64-67.
17. Finegold SM, Molitoris D, Song Y et al. (2002) Gastrointestinal microbiota studies on late-onset autism. Clinical Infectious Diseases, 35, S6-S16.
18. Goel V, Lovlin R, Barton R, Lyon MR, Bauer R, Lee TDG, Basu TK (2004) Efficacy of a standardized Echinacea preparation (Echinilin™) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial. Journal of Clinical Pharmacy and Therapeutics, 29, 75-83.
19. Swanson KMJ, Petran RL, Hanlin JH (2001) Culture methods for enumeration of microorganisms. In: Downes FP, Ito K, eds. Compendium of methods for the microbiological examination of foods, 4th edn. Washington, DC: American Public Health Association, 53-62.
20. Moore WEC, Moore LH (1995) Intestinal floras of populations that have a high risk of colon cancer. Applied and Environmental Microbiology, 61, 3202-3207.
21. Basset C, Holton J, Bazeos A, Vaira D, Bloom S (2004) Are Helicobacteria species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Digestive Diseases and Sciences, 49, 1425-1432.
22. Prindiville TP, Sheikh RA, Cohen SH, Tang YJ, Cantrell MC, Silva J (2000) Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerging Infectious Diseases, 6, 171-174.
23. Pathela P, Hasan KZ, Roy E, Alam E (2005) Enterotoxigenic Bacteroides fragilis-associated diarrhea in children 0-2 years of age in rural Bangladesh. Journal of Infectious Diseases, 191, 1245-1252.
24. Zhang G, Svenungsson B, Karnell A, Weintraub A (1999) Prevalence of enterotoxigenic Bacteroides fragilis in adult patients with diarrhea and healthy controls. Clinical Infectious Diseases, 29, 590-594.
25. Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS (eds) (1998) Echinacea purpurea herb. In: The complete German commission E monographs. Austin, TX: American Botanical Council, 122-123.
26. Woodmansey EJ, McMurdo MET, Macfarlane GT, Macfarlane S (2004) Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic treated elderly subjects. Applied and Environmental Microbiology, 70, 6113-6122.
27. Tannock GW (1995) Normal microbiota. An introduction to microbes inhabiting the human body. London: Chapman & Hall.